×
ADVERTISEMENT

OCTOBER 12, 2020

Immunotherapy Toxicities

Early Recognition, Management, And Concerns in the COVID-19 Pandemic

Samantha Spencer, PharmD, BCPS
Clinical Assistant Professor
University of Illinois at Chicago
Drug Information Group
Chicago, Illinois

Immune checkpoint inhibitors and adoptive cell transfer therapies have unlocked new avenues to treat cancer, but they are associated with immune-related adverse events (irAEs). Pharmacists can play an integral role in managing these irAEs and educating patients and other health care professionals about them.

image

The immune system recognizes tumors and eradicates cancerous